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Abstract 
The effect of serum on liver uptake of liposomes with different compositions was investigated using a single-pass liver perfusion 
technique. Among the liposomes tested are those containing CL, PA, DPGS, PE or glycolipids uch as PI, GD, GTjb and aGM 1. 
Liposomes containing PA, CL and DPGS showed high level of liver uptake in the absence of serum. Presence of serum decreased the 
total liver uptake for liposomes containing CL and PA by 50% and did not affect the level of liver uptake for DPGS-containing 
liposomes. The presence of serum, however, significantly increased the liposome uptake by the perfused liver for PG, PE and aGM~ 
liposomes. Liposomes containing PI showed a minimal iver uptake regardless of serum presence. Fluorescence microscopic studies using 
a dual fluorescence label system in combination with Kupffer cell elimination technique showed that, in addition to the dominant role of 
Kupffer cells in taking up liposomes, non-Kupffer cells may also be involved in taking up CL and DCP-containing liposomes. 
Competition experiments using various liposome compositions indicated that liposome uptake by the liver cells may involve different 
receptors. Serum activity in enhancing the liver uptake for PE- and aGMl-containing liposomes can be blocked by treatment of serum 
with EDTA, EGTA/Mg 2+ and high temperature (56°C), suggesting the involvement of complement system. Results from this study 
support he conclusion that blood clearance of liposomes by the liver involves two independent mechanisms, one requires erum opsonins 
and the other does not. 
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1, Introduction to maintain a high drug concentration i  the blood for a 
long period of time without causing serious toxic effect 
Liposomes have been considered as one of the most and (3) to concentrate the drug molecules at the target site 
promising carriers for drug delivery [1-4]. Many reports through either an active or passive targeting mechanism. 
have appeared in the literature in recent years, demonstrat- Another important factor that has become apparent from 
ing that the therapeutic efficacy of a pharmaceutical gent these in vivo studies is that one needs to control the blood 
can be significantly increased when administered in a kinetics and tissue distribution of the liposomes in order to 
liposomal formulation [1,2]. The functions of liposomes further improve the therapeutic efficacy. For example, 
under such in vivo conditions include: (1) to protect the liposomes which can stay in circulation for prolonged 
drug molecules against he degradation by body fluid, (2) period of time to extravasate the leaky vessels of solid 
tumor are very useful in delivering antitumor drugs for 
cancer chemotherapy [5-8]. To achieve this goal, however, Abbreviations: aGM~, gangliotetraosyl ceramide; Chol, cholesterol; 
CL, cardiolipin; C12MBP, dichloromethylene bisphosphonate; DCP, we will have to understand the physical, chemical and 
dicetyl phosphate; DiI, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbo- biological factors that regulate the blood clearance and 
cyanine perchlorate; DPGS, 1,2-dipalmitoyl-sn-glycerol-3-succinate; issue distribution of liposomes. 
DTPA-SA, diethylenetriaminepentaacetic id stearylamide; GDib, lit is known for some time that liposomes, once injected 
disialoganglioside; GTib, trisialoganglioside; PA, phosphatidic a id; PC, into the animals, are quickly eliminated from the blood by 
phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidyl- 
glycerol; PI, phosphatidylinositol; PS, phosphatidylserine, the reticuloendothelial system (RES), primarily the 
* Corresponding author. Fax: + 1 (412) 6482116. macrophages of the liver [9]. The clearance of liposomes 
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from the blood is mainly dependent on liposome composi- 2. Materials and methods 
tion and diameter [10-12]. Generally, liposomes contain- 
ing negatively charged lipids such as phosphatidylserine 2.1. Materials 
(PS), phosphatidylglycerol (PG), phosphatidic acid (PA) or 
cardiolipin (CL) are cleared much faster than those con- Phospholipids including egg phosphatidylcholine (PC) 
taining neutral ipids. However, inclusion into liposome and phosphatidylethanolamine (PE), bovine brain phos- 
bilayer of glycolipids uch as monosialoganglioside (GM1), phatidylserine (PS), phosphatidic acid (PA), phosphatidyl- 
phosphatidylinositol (PI) or amphipathic polyethylene gly- glycerol (PG), phosphatidylinositol (PI), 1,2-dipalmitoyl- 
col [13-15] significantly decreases the rate of liposome sn-glycerol-3-succinate (DPGS)and cardiolipin (CL)were 
clearance. With respect o the effect of liposome size on from Avanti Polar Lipids (Birmingham, AL). Glycolipids 
the rate of blood clearance, liposomes with large diameters including phosphatidylinositol, disialoganglioside (GD~b), 
are cleared faster than those with smaller diameters of the trisialoganglioside (GTlb) and gangliotetraosyl ceramide 
same composition. However, the basic principles behind (aGM l) were purchased from Matreya (Pleasant Gap, PA). 
these well-known phenomena remain unknown. For exam- Cholesterol (Chol) and dicetyl phosphate (DCP) were or- 
pie, it is not very clear why inclusion of small amount of dered from Sigma (St. Louis, MO). Dichloromethylene 
specific lipid into the liposome bilayer could dramatically bisphosphonate (CI2 MBP) was a kind gift from Boehringer 
change the liposome retention time in the blood circulation Mannheim, Germany. 1,1'-Dioctadecyl-3,3,3',3'-tetrameth- 
and the level of liposome accumulation i the liver, ylindocarbocyanine perchlorate (DiI) was from Molecular 
To understand the roles of these added lipids in affect- Probes (Eugene, OR). The fluorescence beads (Fluo- 
ing the liposome clearance by the liver, we have recently resbrite YG Microspheres, 1 /zm in diameter) were or- 
developed a single-pass liver perfusion model system dered from Polyscience (Warrington, PA). 111INC13 (cartier 
[16,17]. Using mouse liver as a model, we have demon- free) was purchased from New England Nuclear (Wilming- 
strated that inclusion of negatively charged lipids such as ton, DE). Diethylenetriaminepentaacitic d stearylamide 
PS and DCP into the liposomes increases the liposome (DTPA-SA) was kindly provided by Dr. Leaf Huang (De- 
uptake by the perfused liver. Inclusion of other types of partment of Pharmacology, University of Pittsburgh). Syn- 
lipids such as GM I or PEG-PE into liposomes decreases thesis and 11~In labeling of DTPA-SA has been described 
the liposome uptake by the perfused liver. Such liposome previously [18]. Animals (CD-1 mice, male, 20-25 g) 
uptake pattern correlates very well with that obtained in were from Charles River (Wilmington, MA). 
vivo. Experiments designed to identify the factors that 
control the high liver uptake of liposomes containing PS 2.2. Liposome preparation 
and DCP showed that these types of negatively charged 
liposomes were taken up by the liver through a mechanism Liposomes composed of PC/Chol and an additional 
of direct recognition and without involving the serum lipid component with a molar ratio of 10:5:1 
opsonins [17]. As these results were obtained from a (PC/Chol/additional lipid))were prepared by a method 
limited number of liposome compositions, we decided to of extrusion [19]. For a standard preparation, lipids in the 
test whether such serum-independent mechanism can apply desired ratio were mixed in chloroform. The organic sol- 
to other types of liposomes. In this study, we have exam- vent was evaporated under a stream of N 2 gas and the lipid 
ined the effect of serum on the liver uptake of PC/Chol films were then vacuum desiccated for at least 2 h to 
based liposomes containing CL, PA, PG, DPGS, PE, or remove the residual organic solvent. The dried lipid films 
glycolipids including PI, aGM 1, GDlb or GT~b using the were hydrated in PBS (pH 7.4) for a minimum of 2 h at a 
same single-pass liver perfusion system. We also examined lipid concentration of 10 mM. The lipid suspension was 
whether Kupffer cells are solely responsible for liver up- then extruded 10 times through polycarbonate filter 
take of liposomes. (Nucleopore) with a defined pore size using LiposoFast 
The results from these experiments as presented in this extrusion device (Avestin, Canada). Multilamellar lipo- 
paper suggest that both serum-dependent a d serum-inde- somes prepared with an average diameter between 300-500 
pendent mechanisms for liposome clearance coexist in the nm, as measured by light scattering using Coulter N4SD 
mouse. Depending on lipid composition, liposomes can be particle size analyzer (Coulter Electronic, Hiateah, FL), 
taken up by liver cells either through a serum-dependent were used in this study. 
mechanism or a serum-independent mechanism. We also To label liposomes, a trace amount of either ~tlln- 
demonstrated that while the Kupffer cells are the major DTPA-SA or DiI (25 /xg per 5 /zmol lipid) were mixed 
cell type responsible for liposome uptake, it is evident hat with other lipids at the beginning of the liposome prepara- 
non-Kupffer cells in the liver may also participate in tion. 
taking up liposomes with a particular composition. Results C12MBP-containing liposomes were prepared according 
from experiments designed to characterize the molecules to the method previously described by Van Rooijen [20]. 
involved in liver uptake of different ypes of liposomes Briefly, the dried lipid films containing 30 /xmol total 
suggest the existence of multiple receptors for lipids, lipids (PC/Chol/PS = 10:5:1, molar ratio) were hydrated 
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in CI2MBP (75 mg/ml in H20). The osmolarity of the presented as the percentage of the total liposomes per- 
solution is equivalent to that of serum. Trace amount of fused. 
[3H]glucose was included as the water-soluble marker to For competition experiments, the test liposomes (ill in - 
estimate the entrapment efficiency of ClzMBP. The lipid labeled) were mixed with competing liposomes (2 /zmol 
suspension was then gently vortexed. To remove unencap- total lipids, without labeling) and the liver perfusion was 
sulated C12MBP, the lipid suspension was first centrifuged performed using the protocols described above. 
for 30 min in a desk top centrifuge (Sorval RT600B) at a 
speed of 3000 rpm. Liposomes floated to the top under 2.4. Serum treatment 
such conditions were collected and resuspended in 1.5 ml 
PBS (pH 7.4). The liposome suspension was then cen- To 200 /xl of freshly collected mouse serum, either 24 
trifuged in a microcentrifuge (12000 × g, 10 min). The /xl of EDTA (100 mM) or 30 /.tl of EGTA/Mg 2÷ (80 
liposome pellet was washed two more times under the mM/20 mM) was added. The final volume of the mixture 
identical procedure using the microcentrifuge and finally was adjusted to 240/.tl by saline. For control group, 40/zl 
resuspended in 1 ml of PBS. The estimated encapsulation of saline was directly added to the serum. The mixture was 
efficiency for C12MBP under these conditions is about 30 incubated for 30 min at 37°C before mixing with lipo- 
/~g per/zmol total lipids, somes. Inactivation of complement components was per- 
formed at 56°C for 30 rain using same amount of serum 
2.3. Single-pass liver perfusion diluted with 40 /zl saline. 
Liposomes (12 /zl containing 0.12 /zmol total lipids) 2.5. Kupffer cell elimination 
were mixed with 200 /zl of either freshly collected mouse 
serum or PBS and incubated at 37°C for 10 min. The To each mouse, 100 tzl of liposomes containing 3 
mixture was then diluted into 2.4 ml with prewarmed /xmol total lipids with or without C12MBP entrapped 
(37°C) Krebs-Henseleit Buffer (KHB) (pH 7.2, saturated inside were intravenously injected. 24 h after the injection, 
with 95% 02/5% CO2). 2 ml of the mixture were then a single-pass perfusion was performed on these animals to 
perfused through the prewashed (by 5 ml of prewarmed examine the effect of the liposomal CI2MBP treatment on 
KHB, pH 7.2) liver via the portal vein. Animals were liposome uptake by the liver. 
anesthetized by 2',2',2'-tribromoethanol (0.6 ml/mouse, 
20 mg/ml, i.p.) for cannulation. An incision at inferior 2.6. Fluorescence microscopic studies 
vena cava was made to drain the blood and the perfusate. 
Unbound liposomes in the liver were removed by perfus- Fluorescence-labeled polystyrene beads containing 1.2 • 
ing through the liver with 5 ml of saline. The rate of 10 9 particles in 100 /xl were injected into the mouse via 
perfusion was kept at 2 ml/min. The amount of liposomes tail vein. 1 h post injection, animals were anesthetized and 
taken up by the liver was analyzed by measuring the total the liver perfusion was performed with DiI-labeled lipo- 
UlIn radioactivity in the liver using a gamma counter and somes (2 btmol total lipids). Liver sections (10 /zm in 
thickness) were immediately prepared by a standard 
cryosection procedure [21], observed and the pictures were 
7o taken under a fluorescence microscope. 
. . . .  1 
60 • +Serum 
3. Results 
50 
m 
40- 3.1. Effect of serum on liposome uptake 
.~ 30 T Fig. 1 shows the liver uptake of radio-labeled liposomes 
i t '~  [ '~  after single pass perfusion through the mouse liver for a 
20. variety of compositions, all with PC/Chol as the matrix 
10- lipid, and an average diameter of about 300-500 nm 
~_~ (mean from unimodel analysis). On the basis of the total 
0 ~ ~ liposome uptake by the perfused liver, three patterns were 
F- 
~ o o ~ -~ ~ ~ observed with respect o the effect of serum on liposome 
~" ~ ~e ~ ~ ~ ~ ~ uptake by the liver: positive, negative and no effect. Serum 
enhanced the liver uptake of liposomes containing aGM 1, 
UI'OSOM~CO~a, osnaoN PG and PE. In the absence of serum, only about 2% of 
Fig. 1. Effect of serum on liposome uptake by the perfused mouse liver, these liposomes were taken up by the liver after perfusion. 
Data represent mean+ S.D., n = 3-5. The total liposome uptake in the presence of serum in- 
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creased to about 20% for aGM 1 and PE liposomes, and 100- A 
about 5% for liposomes containing PG. Under these exper- 
imental conditions, serum increased the total liver uptake 80- 
of these liposomes by 3-10-fold, indicating that serum 
opsonin plays a dominant role in determining the extent of z 60. 
liposome clearance in vivo. Negative effect of serum on 
the level of liposome uptake by the liver was observed ~: 
with liposomes containing CL or PA. For example, about z 40. 
20% of total perfused liposomes containing PA was taken 
up by the liver in the absence of serum while the total 2o 
liposome uptake by the liver dropped to about 10% when 
serum was present. A similar level of reduction (50%) in 0 
liver uptake by serum treatment was also seenin l ipo-  ~ ~ ~ i i c
somes containing CL (from about 60% to 30%). The last ,~ ,, ,. 
pattern observed was that in which serum did not affect he ~ ~ ~ i " 
level of liposome uptake by the perfused liver. Liposomes, ~STUeOSOMES -- 
belonging to this category, include those containing PI 100 
(2%), GTlb (6%) and DPGS (17%). B 
Compared to about 10% of liver uptake for PC/Chol 8o 
liposomes under the same experimental conditions [17] and 
using the level of liver uptake in the presence of serum for 
comparison, inclusion into the lipid bilayer of PI, GD, z 60 
GTIb and PG decreased liposome uptake by the liver. N 
Conversely, aGM 1, PA, CL, DPGS and PE increased the ~ 40t "[- -l- "l- I 
liposome uptake by the perfused liver. ,~ 
20 
3.2. Liver uptake of liposomes in the presence of excess 
amount of liposomes with various composition 
O" 
PC/ChoI/PE PC/ChoI/aGM 1 
Increase in the total liposome uptake by the liver in the 
absence of serum for CL, PA and DPGS in Fig. 1 and by TEST LIPOSOMES 
PS and DCP described in our previous report [17] would Fig. 2. Inhibition of liver uptake of liposomes by different liposome 
composition. HJln-labeled test liposomes (0.1 /.tmol total lipid with 
suggest hat these lipids provide the liposome with higher composition listed on X-axis) were mixed with unlabeled liposomes of 
affinity to liver cells that are involved in taking up lipo- different compositions (2 /xmol total lipids) and liver perfusion was then 
somes. It would also suggest hat there are specific mem- performed. The percent inhibition was calculated by dividing the differ- 
brane molecules (receptor) for these lipids on the cell ence between the total liver uptake in the absence and presence of 
surface. With respect o these receptors, it is possible that competing liposomes by the liver uptake in the absence of competing 
liposomes. Data represent the mean+S.D., n = 3-5. (A) Inhibition of 
the binding of liposomes with different compositions in- serum-independent liver uptake of liposomes. Competing liposomes con- 
volves only one type of membrane r ceptor. The affinity of taining PS (lst bar, [] ), CL (2nd bar, • ), PA (3rd bar), DPGS (4th bar), 
such receptor varies with the structure of the functional or DCP (5th bar). (B) Inhibition of serum-dependent liposome uptake. 
lipid in the liposome bilayer. Liposomes containing the Same experimental conditions were used as in A except that the test 
lipids with higher affinity will be taken up by liver cells liposomes were preincubated with mouse serum before being mixed with 
the competing liposomes. Competing liposomes containing PS (lst bar, 
more efficiently than those containing the lipids that ex- n), CL (2nd bar, •), or DCP (3rd bar). 
hibit lower affinity. Alternatively, it is also possible that 
there are multiple molecules involved. The level of lipo- 
some uptake by the liver cells depends on the number of uptake for the test liposomes was analyzed. As seen in Fig. 
binding sites available for liposome binding and the affin- 2A, the effect of the excess amount of competing lipo- 
ity between the receptor and the lipid component. To test somes on liver uptake varies among the liposomes tested. 
these possibilities, a competition experiment was per- Taking PS-containing liposomes as an example, the total 
formed using liposomes containing PS, DCP, CL, PA and level of liposome uptake by the liver was decreased in the 
DPGS. In these experiments, 111 In-labeled liposomes (0.1 presence of the excess amount of competing liposomes. As 
/xmol total lipids) were mixed with 2 /xmol non-labeled expected, about 80% (from 33% uptake to 6%) of the liver 
liposomes with the same or different lipid composition, uptake for 11 l In-labeled PS-containing liposomes was 
The resulting liposomes after mixing the labeled (test blocked when 2 /xmol of same liposomes were included. 
liposomes) with the unlabeled (competing liposomes) were Liposomes containing CL exhibited lower but significant 
then perfused through the mouse liver and the total liver activity in inhibiting the liver uptake of PS-containing 
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liposomes. Liposomes containing PA, DCP and DPGS by the presence of competing liposomes. All liposomes 
showed similar inhibition activity with the inhibition level tested for competition (PS-, CL- and DCP-containing lipo- 
of about 25%. Similar inhibition pattern was also seen somes) were effective in blocking the liver uptake of 
when CL-containing liposomes were used as the test lipo- liposomes containing either PA or DPGS. When DCP-con- 
somes. 60% of liver uptake was inhibited when 2 /xmol of taining liposomes were used as the test liposomes, PS-con- 
same liposomes was used. Presence of PS-containing lipo- taining liposomes howed much lower inhibition activity 
somes inhibited about 50% liver uptake for CL-containing compared to those containing CL, PA or DPGS. 
liposomes. Again, liposomes containing either DCP, PA or Theoretically, if the liver uptake for negatively charged 
DPGS showed much lower inhibition activity (25% inhibi- liposomes as shown in Fig. 2A involves the specific 
tion), receptors for negatively charged phospholipids such as PS, 
Different from the inhibition pattern observed in PS- CL, DCP, PA and DPGS, serum-dependent liposome up- 
and CL-containing liposomes, the liver uptake of lipo- take by the liver should not be sensitive to the presence of 
somes containing PA and DPGS was more easily inhibited these negatively charged liposomes because the receptors 
Fig. 3. Fluorescence microscopic studies of liposome localization in the liver. Fluorescence labeled polystyrene beads with a diameter of 1 /zm (1.2 • 109 
beads/mouse) were injected to mouse via tail vein to label the Kupffer cells. A standard liver perfusion in these animals was performed with DiI-labeled 
liposomes (2 /xmol total lipid) of various lipid compositions. Cryosections of the liver were made using Cryostat (Jung Frigocut 2800N) and examined 
under a fluorescence microscope. Pictures were taken using double exposure technique. Yellow color is from polystyrene beads and red color indicates the 
location of liposomes. Large arrow in A points the co-localization of polystyrene beads with liposomes and small arrows in D and E show different 
localization of polystyrene beads and liposomes. Liver was perfused with liposomes containing (A) PS, (B) CL, (C) aGM 1 , (D) PE or (E) DCP. Liposomes 
containing aGM l and PE were preincubated with mouse serum for 10 min at 37°C before being perfused through the liver. The bar in C represents 20/zm. 
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involved in taking up these types of liposomes hould be 70- 
specific for opsonins bound to liposome surface. Indeed, as 60. ~q 
shown in Fig. 2B, presence of the excess amount of / liposomes containing either CL, PS and DCP did not 50. significantly affect the level of liposome uptake by the ~ 1- 
perfused liver for liposomes of PE and aGM 1. Less than ,~ 40. .L. 
20% ofliposome uptake by the liver was inhibited when ~ i ~ I l I L  ~ 
10 folds in excess of negatively charged liposomes were ~ 30. 
present. 20. 
3.3. Liver uptake of liposomes involves different cell types lo 
0 
To test whether liposome uptake by the liver involves ~ ~ I ~ ,~ 
different cell types, two independent approaches were 
taken. The first approach was based on the known informa- ~ ~ ~ i 
tion that the uptake of polystyrene beads by the liver is UVOSOMECOmrOSrnON 
exclusively mediated by the Kupffer cells [22]. In these Fig. 4. Effect of Kupffer cell elimination using liposomal C12MBP on the 
experiments, fluorescence labeled polystyrene beads were liver uptake of liposomes. Mouse was injected with 3 p.mol of plain 
injected into animals. One hour after the injection, liver liposomes (PC/Chol/PS) or liposomes containing about 90 /zg of 
perfusion was performed using different ypes of lipo- C12MBP. 24 h post injection, single-pass liver perfusion of Ill In-labeled 
somes labeled with DiI, a commonly used fluorescence liposomes was then performed on these animals according to the standard 
procedure. (El) treated with empty liposomes and (hatched bar) treated 
marker for membrane studies [23], and the co-localization with C12MBP-containing liposomes. Data present mean+ S.D. (n = 3-5). 
of both fluorescence markers was then examined using a 
standard fluorescence microscopic technique. It is evident 
in Fig. 3 that two distinct distribution patterns of the completely abolished in animals pretreated with liposomal 
fluorescence probes were obtained. For liposomes contain- C12MBP. These results strongly suggest the involvement 
ing PS, PE and aGM 1, DiI (red color) was well co-local- of non-Kupffer cells for CL- and DCP-containing lipo- 
ized with that of Fluoresbrite YG Microspheres (Fig. 3A, somes. The Kupffer cells, however, are solely responsible 
C and D), suggesting that the Kupffer cells are responsible for liver uptake of PS-, PE-, and aGMl-containing lipo- 
for the uptake of these liposomes. For CL- and DCP-con- somes. These results upport the conclusion obtained from 
taining liposomes, however, only partial co-localization of our microscopic studies (Fig. 3). 
DiI and the fluorescence-labeled b ads was observed (Fig. 
3B and E). Such partial co-localization would suggest the 3.4. Serum enhanced liver uptake ofliposomes involves the 
involvement of both Kupffer and non-Kupffer cells in complement system 
taking up CL- and DCP-containing liposomes. 
If both Kupffer and non-Kupffer cells are involved in Recent results from this laboratory using freshly col- 
the uptake of CL- and DCP-containing liposomes, one lected human serum showed that the serum components 
would predict hat elimination of Kupffer cells from the that are responsible for the enhanced liposome uptake are 
liver should only partially affect the total liposome uptake those involved in complement activation [16]. To test 
by the liver. In the same notion, for liposomes that are whether this is also true for mouse system, freshly col- 
taken up solely by the Kupffer cells, liposome uptake by lected mouse serum was treated under the conditions that 
the liver should be inhibited if these cells are eliminated are known to block the complement activation pathway 
from liver. To test this hypothesis and confirm the conclu- [24]. As shown in Fig. 5, over 90% of serum-mediated 
sion drawn from data shown in Fig. 3, we have used a liposome uptake by the perfused liver were blocked by 
macrophage suicide reagent, C12MBP. In these experi- pretreatment of serum with either EDTA, EGTA/Mg 2÷ or 
ments, animals were pre-injected with 90 ~g of C12MBP high temperature (56°C for 30 min). Identical results were 
encapsulated into liposomes composed of PC/Chol/PS. obtained for liposomes either containing PE or aGM 1, 
24 h later, standard perfusion experiments were performed suggesting that complement components are responsible 
to check the total liposome uptake by the liver. As shown for serum-mediated liposome uptake by the liver. 
in Fig. 4, the total liver uptake for CL-containing lipo- 
somes decreased only about 50% in comparison to the 
control. The total liver uptake for DCP-containing lipo- 4. Discussion 
somes was also partially inhibited, being about 20% in 
treated animals compared to about 28% in the control The mechanisms involved in liposome clearance by the 
group. However, the liver uptake for other types of lipo- liver are fairly complicated. However, data presented in 
somes including those containing PS, PE and aGM 1 was this paper and those of our previous publications [16,17] 
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20- lipids by membrane receptors of the liver cells. One com- 
i mon feature for these iiposomes is that the negatively 
charged head groups of these negatively charged phospho- 
15 lipids are directly exposed to the liposome surface. The 
reason for the low level of liver uptake for PG-containing 
liposomes in the absence of serum, even though they 
[.., 10" 
a, contain negatively charged phosphate group, is probably 
because the phosphate groups of PG on liposome surface 
are not recognized by these membrane receptors. This may 
5 
be due to the steric hindrance provided by glycerol head 
group on PG. Low level of liver uptake for PI-containing 
0 ~ liposomes may be due to the same mechanism. In the same 
PC/Chol/aGM1 PC/Chol/PE notion, 3-fold increase in liver uptake for GTrb-containing 
LIPOSOMES liposomes, compared to the level for PI-containing lipo- 
Fig. 5. Effect of blocking the complement system on the serum-mediated somes, would suggest hat there are certain amounts of 
liposome uptake by the perfused liver. (lst bar, C3) serum without negatively charged carboxyl groups on GTlb-containing 
treatment. (2nd bar) serum treated with EDTA, (3rd bar) serum treated liposomes that are available for recognition. Such low 
with EGTA/Mg 2+ and (4th bar) serum treated at 56°C. Data represent level of exposure, although sufficient o result in a de- 
mean+S.D. (n=3). creased liposome circulation time in vivo [10], is not 
enough to result in a high level of liver uptake in our 
show that two independent mechanisms are involved, one perfusion system. Such explanation is consistent with the 
is mediated by serum opsonins and the other is not. For hypothesis that the hindrance ffect of the sugar moieties 
liposomes containing negatively charged phospholipids on the negative charge plays a key role in the prolongation 
such as PS, CL, DCP, PA and DPGS, it is clear that their of liposome circulation time in blood [10]. 
uptake by the liver is through a mechanism of direct It is evident from Fig. 1 that the clearance of liposomes 
recognition, without involving the serum components. In containing PE and aGM l in vivo involves serum opsonins. 
contrast, the liver uptake of liposomes containing aGMI, Such serum mediated liposome uptake has been reported 
PE and PG is mediated by complement components. Fur- by many laboratories (for review, see [25]) including ours 
thermore, while it is true that liver Kupffer cells are mainly [16,17,26,27]. The loss of serum activity in increasing the 
responsible for liposome clearance, other types of liver liver uptake for PE- and aGMl-containing liposomes by 
cells may also participate in liposome uptake. EDTA and EGTA/Mg 2+ would suggest that activation of 
The level of liposome uptake by the liver is controlled complement system by these liposomes is through the 
by the structure of the hydrophilic head groups covering classic pathway. Activation of complement system by PE 
the liposome surface. Except for PE- and aGMl-containing [28] and other glycolipid such as cetyl mannoside [29] in 
liposomes, all liposomes tested in this study are negatively the form of liposomes has been reported previously. It has 
charged. The fact that not all liposomes howed high liver also been reported that complement system is involved in 
uptake would suggest hat the negatively charged surface the clearance of PG-containing liposomes in vivo [30]. 
is not the determining factor for liposome uptake by the Such conclusion also seems to be true for other types of 
liver. For example, liposomes containing PI, although neg- liposomes in different animal systems [16]. It is not clear at 
atively charged, exhibited a very low liver uptake regard- this moment, however, whether the complement activation 
less of the presence of serum. Furthermore, the mechanism by these lipids involves the antibodies pecific to these 
involved in the liver uptake of negatively charged lipo- lipids. Limited evidence suggests that C3b of the comple- 
somes could be different. PG-containing liposomes are ment system is responsible for the serum mediated lipo- 
likely cleared from blood circulation by the liver through some uptake by the liver [25,27,31]. 
serum-mediated process while those containing PS, DCP, In addition to the fact that serum enhances the liver 
CL, PA, or DPGS are cleared through serum-independent uptake of PE- and aGMi-containing liposomes, data in 
pathway. Thus, it may not be possible to predict he rate of Fig. 1 show that serum decreases the level of liver uptake 
blood clearance of a given type of liposome solely based for CL- and PA-containing liposomes. A similar phe- 
on its surface charge, nomenon has also been seen for PS-containing liposomes 
The high level of liver uptake in the absence of serum [17]. Since such negative effect by the serum was only 
for liposomes containing CL, PA, DPGS (Fig. 1) and PS, observed in liposomes that exhibit high liver binding in the 
DCP in our previous publication [17] appears to support absence of serum and it is not sensitive to the treatment 
the hypothesis that liver uptake of negatively charged designed to inactivate the complement system [16], it is 
liposomes involves the direct recognition of the negatively highly possible that such effect is resulted from the non- 
charged head groups (phosphate group in DCP, PA and specific binding of serum proteins to the surface of these 
CL, and carboxyl group of PS and DPGS) of the phospho- liposomes. Under such a condition, upon the exposure of 
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liposomes to the serum, some serum proteins will non ably related to the double negatively charged phosphate 
specifically adsorb to the liposome surface and provide group in each molecule of CL. Theoretically, among the 
some level of steric hindrance that can interfere with the negatively charged lipids tested, CL may be the only one 
binding of liposomes to the cells through the specific that contains two directly exposed negatively charged 
membrane receptor, The types and amount of serum pro- phosphate groups. Nevertheless, our data suggest he exis- 
teins that can bind to the liposome surface will depend on tence of multiple receptors that are likely involved in 
the surface properties of the liposomes, thus some nega- liposome clearance. 
tively charged liposomes (CL, PA liposomes, Fig. 1) show While it is evident from our results summarized in this 
significant reduction in liposome uptake by the liver and and previous report [17] that different receptors are most 
some liposomes such as those containing DPGS do not likely involved in the uptake of liposomes by the liver, the 
when serum components are present. Different levels of identity and physiological functions of these receptors are 
protein binding to liposomes of various lipid compositions still not known. Concerning the fact that liver cells, espe- 
have been well documented in the literature [32,33]. cially Kupffer cells, are part of immune defense system 
Data in Figs. 3 and 4 suggest hat, while it is true that that keep abnormal substances and cells out of circulation, 
liver Kupffer cells are the major cell type in the liver that it is, therefore, possible that these receptors are involved in 
are responsible for tiposome uptake, non-Kupffer cells the binding of these abnormal substances. For example, it 
may also participate in the uptake of liposomes containing has been reported that PS is exclusively located in the 
CL or DCP. To our knowledge, this is the first time, using inner leaflet of the cell membrane. Appearance of PS on 
large sized liposomes, the involvement of non-Kupffer the outer leaflet of the cell membrane will result in a quick 
cells in the liposome uptake is demonstrated. Taking the clearance of the cells from the blood circulation by the 
fact that the diameter of the liver fenestration is about 100 RES. The mechanisms of such clearance may be similar, if 
nm [34] and the average diameter of our liposomes is not identical, to that of the clearance for PS-containing 
above 300 nm, it is unlikely that the hepatocytes, which liposomes as discussed in this report. Studies to explore 
are located outside the blood vessels, are involved. While the physiological functions of the receptors involved in the 
it is possible that these non-Kupffer cells are some sub- uptake of other types of liposomes uch as those contain- 
classes of macrophages that do not normally take up ing CL, PA, DCP and possibly others are yet to be 
liposomes, it is also possible that other liver cells such as performed. 
the endothelia cells forming the capillary wall of the blood 
vessel are involved. 
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